Responsive image

Common name


BLAH

IUPAC name


BLAH

SMILES


S(=O)O

Common name


BLAH

IUPAC name


BLAH

SMILES


S(=O)O

INCHI


InChI=1S/HO2S/c1-3-2/h(H,1,2)

FORMULA


HO2S

Responsive image

Common name


BLAH

IUPAC name


BLAH





Molecular weight


66.080

clogP


-2.569

clogS


0.833

Frequency


0.0244





HBond Acceptor


2

HBond Donor


2

Total Polar
Surface Area


37.3

Number of Rings


0

Rotatable Bond


0

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD01270 Pipotiazine Responsive image Antipsychotic Agents; Phenothiazines; Nervous System; Psycholeptics; Phenothiazines With Piperidine Structure; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; For the maintenance treatment of chronic non-agitated schizophrenic patients.
FDBD01271 Thioproperazine Responsive image Antipsychotic Agents; Adrenergic alpha-1 Receptor Antagonists; Phenothiazines; Nervous System; Psycholeptics; Phenothiazines With Piperazine Structure; For the treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes.
FDBD01272 Thiothixene Responsive image Antipsychotic Agents; Dopamine Antagonists; Thioxanthenes; Nervous System; Psycholeptics; Thioxanthene Derivatives; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); For the management of schizophrenia.
FDBD01281 Dalfopristin Responsive image Anti-Bacterial Agents; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Macrolides, Lincosamides and Streptogramins; Streptogramins; CYP3A4 Inhibitors; For the treatment of bacterial infections (usually in combination with quinupristin).
FDBD01361 Silver sulfadiazine Responsive image Anti-Bacterial Agents; Anti-Infective Agents, Local; Sulfonamides; Antibiotics, Topical; Dermatologicals; Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.
FDBD01400 Udenafil Responsive image Genito Urinary System and Sex Hormones; Drugs Used in Erectile Dysfunction; Urological Agents; CYP3A4 Inhibitors; Investigated for use/treatment in erectile dysfunction and hypertension.
FDBD01405 Amisulpride Responsive image Antipsychotic Agents; Dopamine Antagonists; Nervous System; Psycholeptics; Benzamides; Investigated for use/treatment in schizophrenia and schizoaffective disorders, mania in bipolar disorder, and depression.
FDBD01406 Simeprevir Responsive image Simeprevir is indicated in patient's with hepatitis C virus (HCV) genotype 1 for the treatment of chronic hepatitis as a combination therapy, which includes peginterferon alfa and ribavirin.
FDBD01597 Dimetotiazine Responsive image Analgesics; Nervous System; Antimigraine Preparations;
FDBD01651 Ceritinib Responsive image Antineoplastic Agents; Protein Kinase Inhibitors; Antineoplastic and Immunomodulating Agents; Ceritinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
71 , 8
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
2pjt_ligand_frag_4.mol2 2pjt 1 -5.21 S(=O)O 3
1tqf_ligand_frag_1.mol2 1tqf 1 -5.15 S(=O)O 3
3b8z_ligand_frag_5.mol2 3b8z 1 -5.15 S(=O)O 3
3hd3_ligand_frag_0.mol2 3hd3 1 -5.15 O=SO 3
2i47_ligand_frag_4.mol2 2i47 1 -5.14 S(=O)O 3
2viy_ligand_frag_8.mol2 2viy 1 -5.14 S(=O)O 3
3b92_ligand_frag_4.mol2 3b92 1 -5.13 O=SO 3
966c_ligand_frag_3.mol2 966c 1 -5.12 S(=O)O 3
2hh5_ligand_frag_0.mol2 2hh5 1 -5.11 OS=O 3
143 , 15